DTL
RARX

Dynamic Technology Lab’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Dynamic Technology Lab’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,435
Closed -$570K – 1430
2019
Q1 		$570K Buy
+25,435
New +$547K 0.09% 373
2018
Q2 		– Sell
-15,010
Closed -$80K – 1474
2018
Q1 		$80K Buy
+15,010
New +$107K 0.01% 982

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Dynamic Technology Lab's RARX Position: Q2 2019 in Review

Dynamic Technology Lab sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2019, closing a stake of 25,435 shares — an estimated $570K sold.

Dynamic Technology Lab first reported a position in RARX in Q1 2018 and held it in 2 quarters. The position peaked at $570K in Q1 2019. 118 funds tracked by Wall St. Rank hold RARX as of Q2 2019.

  • Dynamic Technology Lab reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Dynamic Technology Lab sold 25,435 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $570K.
  • Dynamic Technology Lab first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
  • Dynamic Technology Lab's Ra Pharmaceuticals, Inc. Common Stock position peaked at $570K in Q1 2019.
  • 118 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Dynamic Technology Lab's 13F filing for Q2 2019, filed 14 Aug 2019.